| Medicare CGS | Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (59862) | 2026-09-03 |
| Medicare FCSO | Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM) (58136) | 2026-09-03 |
| Medicare FCSO | Billing and Coding: Non-Invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities (60318) | 2026-09-03 |
| Medicare Novitas | Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM) (58110) | 2026-09-03 |
| Medicare Novitas | Billing and Coding: Non-Invasive Arterial Duplex Ultrasound of the Upper and Lower Extremities (60315) | 2026-09-03 |
| Aetna | Viscosupplementation | 2026-09-02 |
| Aetna | Pulmonary Hypertension Treatments and Selected Indications of Prostanoids | 2026-09-02 |
| HealthPartners | Investigational services - list of non-covered services | 2026-09-02 |
| Medicare WPS | Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM) (58213) | 2026-09-02 |
| UHC Medicare Advantage | Ambulatory EEG Monitoring – Medicare Advantage Medical Policy | 2026-09-01 |